GENEWIZ Week 2024 marks 25 years of multiomics solutions, featuring workshops, an awards program, and networking opportunities for the research community.
Meta Title: AstraZeneca Plc Patent: Improved AAV Vector Production with Specific Plasmid Sequence
Share this article According to GlobalData’s company profile on AstraZeneca, Personalized cancer vaccines was a key innovation area identified from patents. AstraZeneca‘s grant share as